Anjana V Yeldandi

  • 5255 Citations
1986 …2019
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

General surgical pathology, Pulmonary pathology

Certifications and Licenses

Anatomic Pathology
Anatomic Pathology & Clinical Pathology

Training Experience

1990Residency, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital)

Education/Academic qualification

MD, Gandhi Medical College

… → 1982

Research interests

  • Pathology

Fingerprint Dive into the research topics where Anjana V Yeldandi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 12 Similar Profiles
Peroxisome Proliferator-Activated Receptors Medicine & Life Sciences
Lung Medicine & Life Sciences
Liver Medicine & Life Sciences
Peroxisomes Medicine & Life Sciences
Acyl-CoA Oxidase Medicine & Life Sciences
Peroxisome Proliferators Medicine & Life Sciences
Urate Oxidase Medicine & Life Sciences
Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2003 2015

Research Output 1986 2019

Delivery of Immunotherapeutic Nanoparticles to Tumors via Enzyme-Directed Assembly

Battistella, C., Callmann, C. E., Thompson, M. P., Yao, S., Yeldandi, A. V., Hayashi, T., Carson, D. A. & Gianneschi, N. C., Dec 1 2019, In : Advanced Healthcare Materials. 8, 23, 1901105.

Research output: Contribution to journalArticle

Intravenous Administration

Ectopic hamartomatous thymoma in an immunocompromised male

Waters, D., Obeidin, F., Alexiev, B. A., Rao, M. S., Peabody, T. D., Agulnik, M. & Yeldandi, A., Sep 2019, In : Pathology Research and Practice. 215, 9, 152497.

Research output: Contribution to journalArticle

Salivary Glands
Synovial Sarcoma
Direction compound
Pulmonary Vein Stenosis
38 Citations (Scopus)

Single-cell transcriptomic analysis of human lung provides insights into the pathobiology of pulmonary fibrosis

Reyfman, P. A., Walter, J. M., Joshi, N., Anekalla, K. R., McQuattie-Pimentel, A. C., Chiu, S., Fernandez, R., Akbarpour, M., Chen, C. I., Ren, Z., Verma, R., Abdala-Valencia, H., Nam, K., Chi, M., Han, S. H., Gonzalez-Gonzalez, F. J., Soberanes, S., Watanabe, S., Williams, K. J. N., Flozak, A. S. & 29 others, Nicholson, T. T., Morgan, V. K., Winter, D. R., Hinchcliff, M., Hrusch, C. L., Guzy, R. D., Bonham, C. A., Sperling, A. I., Bag, R., Hamanaka, R. B., Mutlu, G. M., Yeldandi, A. V., Marshall, S. A., Shilatifard, A., Amaral, L. A. N., Perlman, H. R., Sznajder, J. I., Christine Argento, A., Gillespie, C. T., Dematte, J., Jain, M., Singer, B., Ridge, K. M., Lam, A. P., Bharat, A., Bhorade, S. M., Gottardi, C., Budinger, GR. S. & Misharin, A., Jun 15 2019, In : American Journal of Respiratory and Critical Care Medicine. 199, 12, p. 1517-1536 20 p.

Research output: Contribution to journalArticle

Open Access
Single-Cell Analysis
Pulmonary Fibrosis
RNA Sequence Analysis
Alveolar Macrophages
1 Citation (Scopus)

The JAK/STAT pathway is activated in systemic sclerosis and is effectively targeted by tofacitinib

Wang, W., Bhattacharyya, S., Goncalves Marangoni, R., Carns, M., Dennis-Aren, K., Yeldandi, A. V., Wei, J. & Varga, J., Jan 1 2019, (Accepted/In press) In : Journal of Scleroderma and Related Disorders.

Research output: Contribution to journalArticle

Systemic Scleroderma